Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01443
|
|||||
Drug Name |
Norverapamil
|
|||||
Synonyms |
Arverapamil; (R)-norverapamil; Agi-003; UNII-3J8P56R04P; (R)-(+)-Nor Verapamil Hydrochloride; 123932-43-4; 3J8P56R04P; Rezular; (+)-norverapamil; (R)-desmethylverapamil; (+)-desmethylverapamil; CHEBI:134082; ZINC13492624; AKOS030532539; Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, (alphaR)-; UNII-957Z3K3R56 component UPKQNCPKPOLASS-AREMUKBSSA-N
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Irritable bowel syndrome [ICD11: DD91.0] | Phase 2 | [1] | |||
Formula |
C26H36N2O4
|
|||||
Canonical SMILES |
CC(C)C(CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
|
|||||
InChI |
InChI=1S/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3
|
|||||
InChIKey |
UPKQNCPKPOLASS-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 67018-85-3
|
|||||
Pharmaceutical Properties | Molecular Weight | 440.6 | Topological Polar Surface Area | 72.7 | ||
Heavy Atom Count | 32 | Rotatable Bond Count | 13 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 6 | |||
XLogP |
3.3
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:134080
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313. | |||||
2 | Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. J Pharmacol Exp Ther. 2000 May;293(2):376-82. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.